Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. (RARE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RARE · as of Jun 8, 2026
Key Statistics
Explore Ultragenyx Pharmaceutical Inc. Data
rare stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 33 · Buy rate: 81.8%
The RARE analyst consensus is Buy, based on ratings from 33 Wall Street analysts over the past 3 months. The average 12-month price target is $48.36, representing +123.99% upside from the current price of $21.59.
Competitors & Peers
rare competitorsRARE
AAPG
APGE
CELC
CGON
CNTAStock Performance
Full HistoryAbout Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing innovative treatments for rare and ultra-rare genetic conditions. Its operations sp…
what is ultragenyx pharmaceutical inc. · rare stock overview · ultragenyx pharmaceutical inc. company profile · who is ultragenyx pharmaceutical inc. ceo · rare NASDAQ · ultragenyx pharmaceutical inc. headquarters · ultragenyx pharmaceutical inc. business segments
About Stock Overview & Key Data
Ultragenyx Pharmaceutical Inc. (RARE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 31, 2014. As of the latest trading session, RARE stock price is $21.59, with a market capitalization of $2.1B. The stock has returned -41.71% over the past 12 months and -6.13% year-to-date.
According to 33 Wall Street analysts, the consensus rating for Ultragenyx Pharmaceutical Inc. stock is Buy, with an average 12-month price target of $48.36. In fiscal year 2025, Ultragenyx Pharmaceutical Inc. reported revenue of $673.0M and net income of -$575.0M. For detailed data — including Ultragenyx Pharmaceutical Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ultragenyx Pharmaceutical Inc. (RARE) stock price is $21.59. The stock is traded on NASDAQ under the ticker symbol RARE. The 52-week range is $18.29 – $42.37.